Health Canada, April 21, 2006
2006-17
April 21, 2006
Warning
Health Canada advises consumers not to use unauthorized products containing anabolic steroids
OTTAWA - Health Canada is advising consumers not
to use five products containing illegal anabolic steroids, as they
can potentially cause serious health issues such as liver disorders
and heart problems.
The five products are: Anabolic Xtreme Superdrol, Methyl-1-P,
Ergomax LMG, Prostanozoland, and FiniGenX Magnum Liquid. They are
not authorized for sale in Canada as either drugs or natural health
products.
Canadians using any of these products or any other supplements
containing anabolic steroids are advised to stop taking these
products immediately and consult with a health care professional.
Anabolic steroids and their derivatives are controlled substances
in Canada under Schedule IV of the Controlled Drugs and
Substances Act. These products are available illegally over the
Internet. Small amounts of Anabolic Xtreme Superdrol, being imported
for personal use, were recently intercepted at the Canada-U.S.
border.
There are serious health risks associated with the use of
anabolic steroids including heart attacks, strokes, reduced
fertility, hardening of the arteries, liver damage, masculinization
of women, and enlargement or tenderness of male breasts or nipples.
To date, no Canadian adverse reactions associated with the use of
these products have been reported to Health Canada.
Health Canada is also warning consumers to be cautious regarding
the purchase of health products over the Internet or from outside of
Canada, as these products may not have been assessed to the same
standards as products approved for sale on the Canadian market.
Authorized drug products [in Canada] will bear either an eight-digit Drug
Identification Number (DIN), a Natural Product Number (NPN), or a
Homeopathic Drug Number (DIN-HM). This authorization indicates that
the products have been assessed by Health Canada for safety,
effectiveness and quality.
On February 6, 2006, Health Canada issued a warning for a similar
product, M1T (methyl-1-testosterone) Andro Technologies. To date,
Health Canada has received one serious adverse reaction report of
liver toxicity involving M1T (methyl-1-testosterone) Andro
Technologies as a suspected agent.
The text in this article was prepared by Health Canada.